The murine intravaginal HSV-2 challenge model for investigation of DNA vaccines.

ABSTRACT: DNA vaccines have been licensed in veterinary medicine and have promise for humans. This format is relatively immunogenic in mice and guinea pigs, the two principle HSV-2 animal models, permitting rapid assessment of vectors, antigens, adjuvants, and delivery systems. Limitations include the relatively poor immunogenicity of naked DNA in humans and the profound differences in HSV-2 pathogenesis between host species. Herein, we detail lessons learned over the last few years investigating candidate DNA vaccines in the progesterone-primed female mouse vaginal model of HSV-2 infection as a guide to investigators in the field.

SUBMITTER: Marshak JO 

PROVIDER: S-EPMC4084910 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature